SCHEMBL18529243

SCHEMBL18529243

CCOC(=O)c1[nH]c(-c2ccc(C)cc2)cc1-c1ccc(C#N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 3/20 0.43
GCGR P47871 1/20 0.42
MAPK14 Q16539 1/20 0.42
MET P08581 1/20 0.42
KDR P35968 1/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
RAB9A P51151 2/20 0.41
TP53 P04637 2/20 0.41
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
KDM1A O60341 6/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GAA P10253 2/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10397352 0.80 MAPK14 (0.61) ALDH1A1KDM4EHPGDGCGRMAPK14
SCHEMBL3344995 0.79 TUBB4A (0.53) ALDH1A1KDM4EHPGDGCGRMAPK14
SCHEMBL12971261 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDGCGRMAPK14
SCHEMBL4717541 0.76 GCGR (0.46) ALDH1A1KDM4EHPGDGCGRMAPT
SCHEMBL1567586 0.75 PTGER2 (0.53) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL18529244 0.74 MAPT (0.53) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL17396092 0.74 MAPT (0.47) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL18529232 0.73 HDAC3 (0.47) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL30741085 0.73 GCGR (0.57) ALDH1A1KDM4EHPGDGCGRMAPT
SCHEMBL29755963 0.73 KDM1A (0.67) KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180251425-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF MYSORE (IN) 2018-09-06 US claimed
EP-3337323-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF University Of Mysore (IN) 2018-06-27 EP claimed
WO-2017029684-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF MYSORE (IN) 2017-02-23 WO claimed
US-20180251425-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF MYSORE (IN) 2018-09-06 US disclosed
EP-3337323-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF University Of Mysore (IN) 2018-06-27 EP disclosed
WO-2017029684-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF MYSORE (IN) 2017-02-23 WO disclosed
WO-2017029684-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF MYSORE (IN) 2017-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180251425-A1 2,3,5 TRISUBSTITUTED PYRROLE DERIVATIVES AS TOPOISOMERASE INHIBITORS AND THERAPEUTIC USES THEREOF TOP1, TOP2A, TOP2B ALDH1A1 3254/4885KDM4E 3517/4885HPGD 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.